TitleThe HDAC6-RNF168 axis regulates H2A/H2A.X ubiquitination to enable double-strand break repair
AuthorsQiu, Lingyu
Xu, Wenchao
Lu, Xiaopeng
Chen, Feng
Chen, Yongcan
Tian, Yuan
Zhu, Qian
Liu, Xiangyu
Wang, Yongqing
Pei, Xin-Hai
Xu, Xingzhi
Zhang, Jun
Zhu, Wei-Guo
AffiliationShenzhen Univ, Med Sch, Dept Biochem & Mol Biol, Int Canc Ctr,Guangdong Key Lab Genome Instabil & H, Shenzhen 518055, Peoples R China
Univ Toledo, Med Ctr, Div Rheumatol & Immunol, 3120 Glendale Ave, Toledo, OH 43614 USA
Shenzhen Univ, Med Sch, Guangdong Key Lab Genome Instabil & Human Dis Prev, Marshall Lab Biomed Engn,Dept Anat & Histol, Shenzhen, 518055, Peoples R China
Shenzhen Univ, Med Sch, Dept Cell Biol & Med Genet, Int Canc Ctr,Guangdong Key Lab Genome Instabil & H, Shenzhen 518055, Peoples R China
Wannan Med Coll, Sch Basic Med Sci, Wuhu 241002, Anhui, Peoples R China
Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Biophys, Beijing 100191, Peoples R China
KeywordsDNA-DAMAGE RESPONSE
HISTONE UBIQUITINATION
RNF168
UBIQUITYLATION
53BP1
RNF8
H2AX
PHOSPHORYLATION
POLYUBIQUITIN
ACETYLATION
Issue Date2023
PublisherNUCLEIC ACIDS RESEARCH
AbstractHistone deacetylase 6 (HDAC6) mediates DNA damage signaling by regulating the mismatch repair and nucleotide excision repair pathways. Whether HDAC6 also mediates DNA double-strand break (DSB) repair is unclear. Here, we report that HDAC6 negatively regulates DSB repair in an enzyme activity-independent manner. In unstressed cells, HDAC6 interacts with H2A/H2A.X to prevent its interaction with the E3 ligase RNF168. Upon sensing DSBs, RNF168 rapidly ubiquitinates HDAC6 at lysine 116, leading to HDAC6 proteasomal degradation and a restored interaction between RNF168 and H2A/H2A.X. H2A/H2A.X is ubiquitinated by RNF168, precipitating the recruitment of DSB repair factors (including 53BP1 and BRCA1) to chromatin and subsequent DNA repair. These findings reveal novel regulatory machinery based on an HDAC6-RNF168 axis that regulates the H2A/H2A.X ubiquitination status. Interfering with this axis might be leveraged to disrupt a key mechanism of cancer cell resistance to genotoxic damage and form a potential therapeutic strategy for cancer.
URIhttp://hdl.handle.net/20.500.11897/689152
ISSN0305-1048
DOI10.1093/nar/gkad631
IndexedSCI(E)
Appears in Collections:医学部待认领

Files in This Work
There are no files associated with this item.

Web of Science®



Checked on Last Week

Scopus®



Checked on Current Time

百度学术™



Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.